Announcement of the Resolutions of the 23rd Extraordinary Meeting of the Ninth Board of Directors of Lianhuan Pharmaceutical
Securities code: 600513 Securities abbreviation: Lianhuan Pharmaceutical Announcement number: 2026-024
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 23rd Extraordinary Meeting of the Ninth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
1. Convening and convening of meetings
The 23rd extraordinary meeting of the ninth board of directors of Jiangsu Lianhuan Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") was held on April 27, 2026 through on-site and communication methods. The notice of this meeting was issued by email on April 23, 2026. 9 directors should be present at the meeting, and 9 directors were actually present. The number of directors present at the meeting complied with the provisions of the Articles of Association. This board meeting was chaired by Mr. Qian Zhenhua, chairman of the company. The meeting went through appropriate convening and notification procedures and complied with the "Company Law of the People's Republic of China" and other relevant laws, regulations and the "Articles of Association". The meeting was legal and valid.
2. Review status of board of directors meeting
The meeting carefully considered the following proposals and unanimously passed the following resolutions after voting by the directors present:
(1) Consideration and approval of the “Company’s First Quarterly Report for 2026”
(Voting results: 9 votes in favor, 0 votes against, 0 abstentions, 0 avoidance votes)
(2) Consideration and approval of the "Proposal on the Appointment of the Company's Deputy General Manager"
This proposal has been reviewed and approved by the Nomination Committee of the Company’s Board of Directors at the second meeting in 2026.
After nomination by the company's general manager and review and approval by the nomination committee of the board of directors, the company's board of directors agreed to appoint Mr. Zhou Rensong as the company's deputy general manager, with a term starting from the date of review and approval by the board of directors and ending on the expiration date of the ninth session of the company's board of directors (announcement number: 2026-025).
(Voting results: 9 votes in favor, 0 votes against, 0 abstentions, 0 avoidance votes)
(3) Consideration and approval of the "Proposal on the Company's Plan to Sign the "Science and Technology Innovation Center Project Admission Contract" with Yangzhou High-tech Industrial Development Zone"
For details, please see the Shanghai Stock Exchange website www.sse.com.cn "Announcement of Lianhuan Pharmaceutical on the company's intention to sign the "Science and Technology Innovation Center Project Admission Contract" with Yangzhou High-tech Industrial Development Zone" (Announcement No.: 2026-026).
(Voting results: 9 votes in favor, 0 votes against, 0 abstentions, 0 avoidance votes)
(4) Deliberation and approval of the "Proposal on the Company's Controlled Subsidiary to Sign the "Pharmaceutical Precision Cold Chain Manufacturing Center Project Admission Contract" with Yangzhou High-tech Industrial Development Zone"
For details, please refer to the Shanghai Stock Exchange website www.sse.com.cn "Lianhuan Pharmaceutical's Proposal on the Company's Holding Subsidiary Signing the "Pharmaceutical Precision Cold Chain Manufacturing Center Project Admission Contract" with Yangzhou High-tech Industrial Development Zone" (Announcement No.: 2026-027).
(Voting results: 9 votes in favor, 0 votes against, 0 abstentions, 0 avoidance votes)
Announcement is hereby made.
Board of Directors of Jiangsu Lianhuan Pharmaceutical Co., Ltd.
April 28, 2026